Literature DB >> 17082774

ADAMTS1 mediates the release of antiangiogenic polypeptides from TSP1 and 2.

Nathan V Lee1, Makoto Sato, Douglas S Annis, Joseph A Loo, Lily Wu, Deane F Mosher, M Luisa Iruela-Arispe.   

Abstract

Matrix metalloproteases regulate both physiological and pathological events by processing matrix proteins and growth factors. ADAMTS1 in particular is required for normal ovulation and renal function and has been shown to modulate angiogenesis. Here we report that TSP1 and 2 are substrates of ADAMTS1. Using a combination of mass spectrometry and Edman degradation, we mapped the cleavage sites and characterized the biological relevance of these processing events. ADAMTS1 cleavage mediates the release of polypeptides from the trimeric structure of both TSP1 and 2 generating a pool of antiangiogenic fragments from matrix-bound thrombospondin. Using neo-epitope antibodies we confirmed that processing occurs during wound healing of wild-type mice. However, TSP1 proteolysis is decreased or absent in ADAMTS1 null mice; this is associated with delayed wound closure and increased angiogenic response. Finally, TSP1-/- endothelial cells revealed that the antiangiogenic response mediated by ADAMTS1 is greatly dependent on TSP1. These findings have unraveled a mechanistic explanation for the angiostatic functions attributed to ADAMTS1 and demonstrated in vivo processing of TSP1 under situations of tissue repair.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17082774      PMCID: PMC1636613          DOI: 10.1038/sj.emboj.7601400

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  60 in total

1.  Versican V1 proteolysis in human aorta in vivo occurs at the Glu441-Ala442 bond, a site that is cleaved by recombinant ADAMTS-1 and ADAMTS-4.

Authors:  J D Sandy; J Westling; R D Kenagy; M L Iruela-Arispe; C Verscharen; J C Rodriguez-Mazaneque; D R Zimmermann; J M Lemire; J W Fischer; T N Wight; A W Clowes
Journal:  J Biol Chem       Date:  2001-01-26       Impact factor: 5.157

2.  Recognition of the N-terminal modules of thrombospondin-1 and thrombospondin-2 by alpha6beta1 integrin.

Authors:  Maria J Calzada; John M Sipes; Henry C Krutzsch; Peter D Yurchenco; Douglas S Annis; Deane F Mosher; David D Roberts
Journal:  J Biol Chem       Date:  2003-08-08       Impact factor: 5.157

3.  ADAMTS1/METH1 inhibits endothelial cell proliferation by direct binding and sequestration of VEGF165.

Authors:  Alfonso Luque; Darren R Carpizo; M Luisa Iruela-Arispe
Journal:  J Biol Chem       Date:  2003-04-25       Impact factor: 5.157

4.  A recombinant NH(2)-terminal heparin-binding domain of the adhesive glycoprotein, thrombospondin-1, promotes endothelial tube formation and cell survival: a possible role for syndecan-4 proteoglycan.

Authors:  Marianna A Ferrari do Outeiro-Bernstein; Sara Santana Nunes; Ana Carolina Magalhães Andrade; Tercia Rodrigues Alves; Chantal Legrand; Verônica Morandi
Journal:  Matrix Biol       Date:  2002-06       Impact factor: 11.583

Review 5.  Basement membranes: structure, assembly and role in tumour angiogenesis.

Authors:  Raghu Kalluri
Journal:  Nat Rev Cancer       Date:  2003-06       Impact factor: 60.716

6.  Matrix metalloproteinase-9-dependent exposure of a cryptic migratory control site in collagen is required before retinal angiogenesis.

Authors:  Masanori Hangai; Norihiko Kitaya; Jingsong Xu; Candy K Chan; Jenny J Kim; Zena Werb; Stephen J Ryan; Peter C Brooks
Journal:  Am J Pathol       Date:  2002-10       Impact factor: 4.307

7.  The lack of thrombospondin-1 (TSP1) dictates the course of wound healing in double-TSP1/TSP2-null mice.

Authors:  Azin Agah; Themis R Kyriakides; Jack Lawler; Paul Bornstein
Journal:  Am J Pathol       Date:  2002-09       Impact factor: 4.307

8.  Alpha4beta1 integrin mediates selective endothelial cell responses to thrombospondins 1 and 2 in vitro and modulates angiogenesis in vivo.

Authors:  Maria J Calzada; Longen Zhou; John M Sipes; Jane Zhang; Henry C Krutzsch; M Luisa Iruela-Arispe; Douglas S Annis; Deane F Mosher; David D Roberts
Journal:  Circ Res       Date:  2003-12-29       Impact factor: 17.367

9.  Processing and localization of ADAMTS-1 and proteolytic cleavage of versican during cumulus matrix expansion and ovulation.

Authors:  Darryl L Russell; Kari M H Doyle; Scott A Ochsner; John D Sandy; JoAnne S Richards
Journal:  J Biol Chem       Date:  2003-08-07       Impact factor: 5.157

10.  Crystal structure of the TSP-1 type 1 repeats: a novel layered fold and its biological implication.

Authors:  Kemin Tan; Mark Duquette; Jin-huan Liu; Yicheng Dong; Rongguang Zhang; Andrzej Joachimiak; Jack Lawler; Jia-huai Wang
Journal:  J Cell Biol       Date:  2002-10-21       Impact factor: 10.539

View more
  86 in total

1.  ADAMTS-2 functions as anti-angiogenic and anti-tumoral molecule independently of its catalytic activity.

Authors:  J Dubail; F Kesteloot; C Deroanne; P Motte; V Lambert; J-M Rakic; C Lapière; B Nusgens; A Colige
Journal:  Cell Mol Life Sci       Date:  2010-06-24       Impact factor: 9.261

2.  The calreticulin-binding sequence of thrombospondin 1 regulates collagen expression and organization during tissue remodeling.

Authors:  Mariya T Sweetwyne; Manuel A Pallero; Ailing Lu; Lauren Van Duyn Graham; Joanne E Murphy-Ullrich
Journal:  Am J Pathol       Date:  2010-08-19       Impact factor: 4.307

3.  Tumor growth inhibitory effect of ADAMTS1 is accompanied by the inhibition of tumor angiogenesis.

Authors:  Masanari Obika; Hiroko Ogawa; Katsuyuki Takahashi; Jiayi Li; Omer Faruk Hatipoglu; Mehmet Zeynel Cilek; Toru Miyoshi; Junko Inagaki; Takashi Ohtsuki; Shozo Kusachi; Yoshifumi Ninomiya; Satoshi Hirohata
Journal:  Cancer Sci       Date:  2012-08-29       Impact factor: 6.716

4.  The ADAMTS13 metalloprotease domain: roles of subsites in enzyme activity and specificity.

Authors:  Rens de Groot; David A Lane; James T B Crawley
Journal:  Blood       Date:  2010-07-20       Impact factor: 22.113

Review 5.  Thrombospondins in the transition from myocardial infarction to heart failure.

Authors:  Jonathan A Kirk; Oscar H Cingolani
Journal:  J Mol Cell Cardiol       Date:  2015-12-10       Impact factor: 5.000

Review 6.  The roles of ADAMTS in angiogenesis and cancer.

Authors:  Yi Sun; Jintuan Huang; Zuli Yang
Journal:  Tumour Biol       Date:  2015-04-28

Review 7.  Role of unusual O-glycans in intercellular signaling.

Authors:  Kelvin B Luther; Robert S Haltiwanger
Journal:  Int J Biochem Cell Biol       Date:  2008-10-08       Impact factor: 5.085

Review 8.  Regulation of thrombospondin1 by extracellular proteases.

Authors:  M Luisa Iruela-Arispe
Journal:  Curr Drug Targets       Date:  2008-10       Impact factor: 3.465

Review 9.  Thrombospondin and apoptosis: molecular mechanisms and use for design of complementation treatments.

Authors:  Y Mirochnik; A Kwiatek; O V Volpert
Journal:  Curr Drug Targets       Date:  2008-10       Impact factor: 3.465

10.  Integration of Two In-depth Quantitative Proteomics Approaches Determines the Kallikrein-related Peptidase 7 (KLK7) Degradome in Ovarian Cancer Cell Secretome.

Authors:  Lakmali Munasinghage Silva; Thomas Kryza; Thomas Stoll; Christine Hoogland; Ying Dong; Carson Ryan Stephens; Marcus Lachlan Hastie; Viktor Magdolen; Oded Kleifeld; Jeffrey John Gorman; Judith Ann Clements
Journal:  Mol Cell Proteomics       Date:  2019-01-31       Impact factor: 5.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.